Global and Japan Hospital-Acquired Disease Testing Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 UTI Testing
1.2.3 SSI Testing
1.2.4 Pneumococcal Infections Testing
1.2.5 Bloodstream Infections Testing
1.2.6 MRSA Testing
1.3 Market by Application
1.3.1 Global Hospital-Acquired Disease Testing Market Share by Application: 2020 VS 2026
1.3.2 Small and Medium Sized Hospitals
1.3.3 Large Sized Hospitals
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Acquired Disease Testing Market Perspective (2015-2026)
2.2 Global Hospital-Acquired Disease Testing Growth Trends by Regions
2.2.1 Hospital-Acquired Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital-Acquired Disease Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hospital-Acquired Disease Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Disease Testing Players by Market Size
3.1.1 Global Top Hospital-Acquired Disease Testing Players by Revenue (2015-2020)
3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2015-2020)
3.2 Global Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Disease Testing Revenue
3.4 Global Hospital-Acquired Disease Testing Market Concentration Ratio
3.4.1 Global Hospital-Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Disease Testing Revenue in 2019
3.5 Key Players Hospital-Acquired Disease Testing Area Served
3.6 Key Players Hospital-Acquired Disease Testing Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-Acquired Disease Testing Breakdown Data by Type (2015-2026)
4.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2015-2020)
4.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2021-2026)
5 Hospital-Acquired Disease Testing Breakdown Data by Application (2015-2026)
5.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2015-2020)
5.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital-Acquired Disease Testing Market Size (2015-2026)
6.2 North America Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
6.3 North America Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
6.4 North America Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Hospital-Acquired Disease Testing Market Size (2015-2026)
7.2 Europe Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
7.3 Europe Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
7.4 Europe Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Hospital-Acquired Disease Testing Market Size (2015-2026)
8.2 China Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
8.3 China Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
8.4 China Hospital-Acquired Disease Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Hospital-Acquired Disease Testing Market Size (2015-2026)
9.2 Japan Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
9.3 Japan Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
9.4 Japan Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Hospital-Acquired Disease Testing Market Size (2015-2026)
10.2 Southeast Asia Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Diatherix Laboratories
11.1.1 Diatherix Laboratories Company Details
11.1.2 Diatherix Laboratories Business Overview
11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Introduction
11.1.4 Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2015-2020))
11.1.5 Diatherix Laboratories Recent Development
11.2 Gen-Probe
11.2.1 Gen-Probe Company Details
11.2.2 Gen-Probe Business Overview
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Introduction
11.2.4 Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
11.2.5 Gen-Probe Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Hospital-Acquired Disease Testing Introduction
11.3.4 Qiagen Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
11.3.5 Qiagen Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Cepheid
11.5.1 Cepheid Company Details
11.5.2 Cepheid Business Overview
11.5.3 Cepheid Hospital-Acquired Disease Testing Introduction
11.5.4 Cepheid Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
11.5.5 Cepheid Recent Development
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Details
11.6.2 Life Technologies Corporation Business Overview
11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Introduction
11.6.4 Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
11.6.5 Life Technologies Corporation Recent Development
11.7 Meridian Biosciences
11.7.1 Meridian Biosciences Company Details
11.7.2 Meridian Biosciences Business Overview
11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Introduction
11.7.4 Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
11.7.5 Meridian Biosciences Recent Development
11.8 Cantel Medical Corporation
11.8.1 Cantel Medical Corporation Company Details
11.8.2 Cantel Medical Corporation Business Overview
11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Introduction
11.8.4 Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
11.8.5 Cantel Medical Corporation Recent Development
11.9 Nordion
11.9.1 Nordion Company Details
11.9.2 Nordion Business Overview
11.9.3 Nordion Hospital-Acquired Disease Testing Introduction
11.9.4 Nordion Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
11.9.5 Nordion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of UTI Testing
Table 4. Key Players of SSI Testing
Table 5. Key Players of Pneumococcal Infections Testing
Table 6. Key Players of Bloodstream Infections Testing
Table 7. Key Players of MRSA Testing
Table 8. Global Hospital-Acquired Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Hospital-Acquired Disease Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Hospital-Acquired Disease Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Hospital-Acquired Disease Testing Market Share by Regions (2015-2020)
Table 12. Global Hospital-Acquired Disease Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Hospital-Acquired Disease Testing Market Share by Regions (2021-2026)
Table 14. Hospital-Acquired Disease Testing Market Market Trends
Table 15. Hospital-Acquired Disease Testing Market Drivers
Table 16. Hospital-Acquired Disease Testing Market Challenges
Table 17. Hospital-Acquired Disease Testing Market Restraints
Table 18. Global Hospital-Acquired Disease Testing Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Hospital-Acquired Disease Testing Market Share by Players (2015-2020)
Table 20. Global Top Hospital-Acquired Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Disease Testing as of 2019)
Table 21. Global Hospital-Acquired Disease Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hospital-Acquired Disease Testing Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hospital-Acquired Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Hospital-Acquired Disease Testing Market Size Share by Type (2015-2020)
Table 27. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2021-2026)
Table 28. Global Hospital-Acquired Disease Testing Market Size Share by Application (2015-2020)
Table 29. Global Hospital-Acquired Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Hospital-Acquired Disease Testing Market Size Share by Application (2021-2026)
Table 31. North America Hospital-Acquired Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Hospital-Acquired Disease Testing Market Share by Type (2015-2020)
Table 33. North America Hospital-Acquired Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Hospital-Acquired Disease Testing Market Share by Application (2015-2020)
Table 35. North America Hospital-Acquired Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Hospital-Acquired Disease Testing Market Share by Country (2015-2020)
Table 37. Europe Hospital-Acquired Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Hospital-Acquired Disease Testing Market Share by Type (2015-2020)
Table 39. Europe Hospital-Acquired Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Hospital-Acquired Disease Testing Market Share by Application (2015-2020)
Table 41. Europe Hospital-Acquired Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Hospital-Acquired Disease Testing Market Share by Country (2015-2020)
Table 43. China Hospital-Acquired Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 44. China Hospital-Acquired Disease Testing Market Share by Type (2015-2020)
Table 45. China Hospital-Acquired Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 46. China Hospital-Acquired Disease Testing Market Share by Application (2015-2020)
Table 47. China Hospital-Acquired Disease Testing Market Size by Region (US$ Million) (2015-2020)
Table 48. China Hospital-Acquired Disease Testing Market Share by Region (2015-2020)
Table 49. Japan Hospital-Acquired Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Hospital-Acquired Disease Testing Market Share by Type (2015-2020)
Table 51. Japan Hospital-Acquired Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Hospital-Acquired Disease Testing Market Share by Application (2015-2020)
Table 53. Japan Hospital-Acquired Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Hospital-Acquired Disease Testing Market Share by Country (2015-2020)
Table 55. Southeast Asia Hospital-Acquired Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Hospital-Acquired Disease Testing Market Share by Type (2015-2020)
Table 57. Southeast Asia Hospital-Acquired Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Hospital-Acquired Disease Testing Market Share by Application (2015-2020)
Table 59. Southeast Asia Hospital-Acquired Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Hospital-Acquired Disease Testing Market Share by Country (2015-2020)
Table 61. Diatherix Laboratories Company Details
Table 62. Diatherix Laboratories Business Overview
Table 63. Diatherix Laboratories Product
Table 64. Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 65. Diatherix Laboratories Recent Development
Table 66. Gen-Probe Company Details
Table 67. Gen-Probe Business Overview
Table 68. Gen-Probe Product
Table 69. Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 70. Gen-Probe Recent Development
Table 71. Qiagen Company Details
Table 72. Qiagen Business Overview
Table 73. Qiagen Product
Table 74. Qiagen Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 75. Qiagen Recent Development
Table 76. F. Hoffmann-La Roche Company Details
Table 77. F. Hoffmann-La Roche Business Overview
Table 78. F. Hoffmann-La Roche Product
Table 79. F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 80. F. Hoffmann-La Roche Recent Development
Table 81. Cepheid Company Details
Table 82. Cepheid Business Overview
Table 83. Cepheid Product
Table 84. Cepheid Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 85. Cepheid Recent Development
Table 86. Life Technologies Corporation Company Details
Table 87. Life Technologies Corporation Business Overview
Table 88. Life Technologies Corporation Product
Table 89. Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 90. Life Technologies Corporation Recent Development
Table 91. Meridian Biosciences Company Details
Table 92. Meridian Biosciences Business Overview
Table 93. Meridian Biosciences Product
Table 94. Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 95. Meridian Biosciences Recent Development
Table 96. Cantel Medical Corporation Business Overview
Table 97. Cantel Medical Corporation Product
Table 98. Cantel Medical Corporation Company Details
Table 99. Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 100. Cantel Medical Corporation Recent Development
Table 101. Nordion Company Details
Table 102. Nordion Business Overview
Table 103. Nordion Product
Table 104. Nordion Revenue in Hospital-Acquired Disease Testing Business (2015-2020) (US$ Million)
Table 105. Nordion Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Hospital-Acquired Disease Testing Market Share by Type: 2020 VS 2026
Figure 2. UTI Testing Features
Figure 3. SSI Testing Features
Figure 4. Pneumococcal Infections Testing Features
Figure 5. Bloodstream Infections Testing Features
Figure 6. MRSA Testing Features
Figure 7. Global Hospital-Acquired Disease Testing Market Share by Application: 2020 VS 2026
Figure 8. Small and Medium Sized Hospitals Case Studies
Figure 9. Large Sized Hospitals Case Studies
Figure 10. Hospital-Acquired Disease Testing Report Years Considered
Figure 11. Global Hospital-Acquired Disease Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Hospital-Acquired Disease Testing Market Share by Regions: 2020 VS 2026
Figure 13. Global Hospital-Acquired Disease Testing Market Share by Regions (2021-2026)
Figure 14. Global Hospital-Acquired Disease Testing Market Share by Players in 2019
Figure 15. Global Top Hospital-Acquired Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Disease Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hospital-Acquired Disease Testing Revenue in 2019
Figure 17. North America Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Hospital-Acquired Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Diatherix Laboratories Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 45. Gen-Probe Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 46. Qiagen Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 48. Cepheid Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 49. Life Technologies Corporation Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 50. Meridian Biosciences Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 51. Cantel Medical Corporation Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 52. Nordion Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed